Introduction
It is reasonable to believe that recently sustained fracture has implications on bone turnover. It has been shown by us and by others [1] [2] [3] [4] that a fracture subsequently results in local osteopenia surrounding the fracture site. From histomorphometric analysis of such bone, we know that post-traumatic osteopenia is the result of a high turnover condition, where evidently the bone resorption exceeds that of bone formation [5 6 ]. Furthermore, the fracture healing events may directly have implications on bone formation, and the relative immobilisation following fracture may contribute to an increased bone resorption.
In spite of the well-grounded body of evidence for the general existence of a post-traumatic skeletal high turnover condition, researchers have, by using biochemical markers of bone turnover, not succeeded to fully demonstrate this condition. One reason for this has been a lack of knowledge about baseline levels, before the fracture event, when fractured patients have been followed longitudinally [7] [8] . Other reasons may have been limited number of individuals investigated, or limited information about fracture history, to draw full conclusions.
Biochemical markers of bone turnover have been used for prediction of fracture, by us and by others [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . If baseline levels of these markers would be influenced in either direction by recently or non-recently sustained fracture, such an event would introduce a possible bias, to be controlled for in further studies on prediction of fracture by biochemical markers.
This study was done in order to elucidate whether a retrospectively sustained fracture would have any influence on biochemical markers of bone formation or resorption, and if so, whether such an effect is time dependent. Furthermore, we wanted to find out whether a relative immobilisation, taking place after fracture, has any implications on biochemical markers of bone turnover.
Methods

Subjects
Invited to the study were 1604 women, all 75 years old. The women were identified at random from the city files of Malmö, Sweden. No exclusion criteria were used. The invitation letter was sent out the week following the 75 th birthday of each woman. Of these, 1024 (64%)
women participated in a clinical investigation, where blood and urine samples were collected for assessments of biochemical markers of bone turnover. Reasons for not participating have been reported earlier [20] and were mainly due to unwillingness (n=376), illness (n=139), failed contact (n=32) or death (n=13) before the day of examination. The study was in all parts approved by the local ethics committee.
Fractures
All retrospectively sustained fractures from birth to age 75 were ascertained by three means.
Firstly, the files of the department of radiology at the Malmö University Hospital were searched for all fractures in the 1604 invited women. This is the only hospital serving the city (260 000 inhabitants), and there is, and always has been, only one department of radiology and one department of orthopaedics, which is the only department where fractures are treated in the city. Due to the personal identification number of each Swedish citizen, retrieval of such data is possible, as is avoidance of double entries. This system also allows us to ensure fracture data when a citizen of Malmö has been treated for fracture at another hospital.
Secondly, participating women responded to a questionnaire about retrospectively sustained fractures. Thirdly, this information was confirmed against the files of the departments of radiology and orthopaedics.
Sampling procedures
Non-fasting blood samples were obtained between 08.00 and 13.00. The blood samples were centrifuged and processed within 2 hours after phlebotomy, and stored at -80°C. The urine samples were obtained as first morning void and stored at -80°C.
Bone markers -formation
All samples were analysed at the same time. Inter-and intra-assay coefficients of variation (CV) for the assays have been determined previously at our laboratories. Serum bone-specific alkaline phosphatase (S-Bone ALP) was determined using the Metra BAP immunoassay (Quidel Corporation, San Diego, CA, USA), with inter-and intra-assay CV of 4.4% and 3.6%, respectively. Serum intact and N-Mid osteocalcin were determined using the Elecsys N-MID Osteocalcin immunoassay (S-Total OC; N-MID®; Roche Diagnostics, Mannheim, Germany), with inter-and intra-assay CV of 2.4% and 2.3%, respectively. Serum total carboxylated osteocalcin (S-cOC) was determined by a previously published, in-house assay [21] , with intra-and inter-assay CV of less than 5% and 8%.
Bone markers-resorption
Serum C-terminal cross-linked telopeptides of type I collagen (S-CTX) were determined using the Elecsys ®-CrossLaps immunoassay (Roche Diagnostics)(intra-assay CV 5.9%, interassay CV 5.8%), serum tartrate resistant acid phosphatase type 5b (S-TRACP5b) by a solidphase, immunofixed, enzyme activity assay as described earlier (intra-assay CV 1.8%, interassay CV 2.2%) [22] and urinary deoxypyridinoline/creatinine (U-DPD/crea) by the Metra DPD immunoassay (intra-assay CV of less than 12%, inter-assay CV of less than 10%) (Quidel Corporation, San Diego, CA, USA).
Bone markers-urine osteocalcin
Urine osteocalcin (U-OC) was analysed using two novel, two-site assays, U-MidOC/crea and U-LongOC/crea modified from previously described protocols for serum human osteocalcin [21] . The assay U-MidOC/crea measures all the predominant urine OC fragments, detectable by a two-site immunoassay. In contrast, the assay U-LongOC/crea detects only the longest urine OC fragments [23] . The intra-assay CV's are less than 5%, and interassay CV's less than 8% for both assays [23] .
Other measurements
Urinary creatinine was determined in accordance with the kinetic Jaffé reaction with a
Beckman synchron LX20-4, with CV's of 3% or less. In addition, body weight and time of specimen collection was recorded, as was serum creatinine analysed by standardised methods.
Self-assessed physical activity
A self-assessed questionnaire (earlier validated [24] ) was used to estimate the present activity into eight physical activity levels from 1) bed rest, cannot walk; 2) walking possible with human support only; 3) walking with walking aid, only in-doors; 4) walking with walking aid, in-and out-doors; 5) no walking aid, walks independently without limitation; 6) takes frequent or regular walks; 7) participates in physical activity more strenuous than walking only; and 8) still working, no limitations of mobility.
Statistics
The frequency of retrospectively sustained fracture between the whole population (n=1604) and the women who had their blood and urine sampled (n=1024) was compared with Chisquare analysis. The Shapiro-Wilk test for normal distribution was applied for all markers. STRACP5b, but no other marker, was normally distributed (SW-W>0,95). Statistical calculations were therefore done for all markers, except S-TRACP5b, only after logarithmic transformation. Students t-test was applied when comparison was made between women with retrospective fracture and women without such fracture, or when women with retrospective fracture sustained recently (from age 73.0) were compared with all other women.
Furthermore, in women with recent fracture, the age at the last fracture was compared with the serum or urinary concentrations of bone markers with Pearsons regression. To illustrate marker levels in relation to age at latest retrospective fracture, on a Robust locally-weighted regression method (Lowess smoothing) was used. Marker levels in relation to current level of physical activity were compared with one-way analysis of variance.
We used Statistica 6.1 from Statsoft Inc., OK, USA, for all statistical calculations.
Results
Fractures
Of all 1604 women invited, 727 (45%) had had at least one retrospectively sustained fracture.
The comparing figure for the women who had their blood and urine sampled (n=1024) was 523 (51%), a non-significant difference. Of the 1024 sampled women 100, had sustained at least one fracture after the age of 73.0.
The total number of fractures sustained by all women was 1225, and by the sampled women, All formation and resorption markers were marginally higher (significant, only for U-DPD/crea (p=0.027)) in women who ever had sustained retrospective fracture, compared to women without such fracture (Table 1) . When plotting the marker levels in relation to age at latest fracture, a visual estimation revealed a tendency for all markers to be higher in those women who had had a fracture within a time period of a few years before sampling (Figure1).
There was no difference in body weight (p=0.41), serum sampling time of the day (p=0.26) or serum creatinine (p=0.16) between women with or without ever having a retrospective fracture.
When statistical comparisons were done between women who had fractured themselves after age 73.0 with all other women, S-TRACP5b (p=0.020) and U-LongOC/crea (p=0.040) were higher in the fractured women compared to the others (Table 1) . Again, when only women with retrospective fracture since age 73.0 were taken into account, the levels of all markers, except the two serum osteocalcins, were significantly higher (r= 0.20-0.33, p=0.049-0.001) in women the more recently the fracture had been sustained ( Table 2 , Figures 2 and 3) .
One of the 1024 sampled women was always confined to bed (physical activity class 1). This single woman was therefore excluded from further analysis. Women with ever a retrospective fracture were currently less physically active, than were the never-fractured women (p<0.001). The resorption marker U-DPD/crea (p<0.001) and the urinary osteocalcin ULongOC/crea (p=0.014) were higher in the least active women compared to the most active ones (Figures 4a and 4b) , while there was no clear activity-dependent pattern for any of the other markers.
Discussion
We have failed to find any studies in which the specific aim was to demonstrate levels of different markers of bone turnover in relation to earlier sustained fracture. In a few studies dealing partially with this subject, a firm conclusion has not been reached, partly due to insufficient number of individuals followed up [9 25 26] . The present study involved a sufficient number of women with a sufficient number of fractures sustained, also within a few years prior to sampling, to overcome such a power problem.
The most significant finding in this study is that women with recently sustained fracture have high levels of bone markers, in particular, S-TRACP5b and U-LongOC/crea. Furthermore, within two years, also the formation marker, S-Bone ALP, and the resorption markers, S-CTX and U-DPD/crea, and the urinary Osteocalcin, U-MidOC/crea, were higher the more recently before sampling the fracture had been sustained.
The cutoff limit of two years prior to sampling was chosen based on clinical and scintigraphic experience of fracture consolidation. Interestingly, the results were the same, except for S-CTX which no longer was time dependent, had the cut-off limit instead been chosen to one year prior to sampling (data not shown). On the other hand, this study shows that having ever sustained a fracture seems to influence marker levels in a limited way. Although the absolute levels were somewhat higher in the ever-fractured women compared to the never-fractured women, a significantly higher level was only found for U-DPD/crea.
Neither total (S-Total OC) nor the carboxylated form (S-cOC) of osteocalcin seemed to be influenced in any way by a recently sustained fracture, while the third marker of bone formation analysed, S-Bone ALP, was increased. This is in line with earlier findings that osteocalcin seems to be involved in the early phase of mineralization after fracture, while its presence seems not to be a requirement for the continuous mineralization process [27] .
Alkaline phosphatase (S-Bone ALP), on the other hand, may be more involved also in the continuous mineralization processes [28] . The different markers may thus reflect different stages of osteoblastic development and function, which would be one possible explanation for the divergent findings of the markers of bone formation. These findings do not exclude, however, that there may be a transient increase in serum osteocalcin after fracture [8] .
It is obvious, from a theoretical point of view, that not only bone formation, but also bone resorption, should be increased compared to baseline after fracture. Bone resorption was evaluated in this paper by three generally accepted biochemical markers of resorption (S-CTX, S-TRACP5b and U-DPD/crea), and by two markers for which we have some evidence to believe that they are also markers of resorption rather than formation (U-LongOC/crea and U-MidOC/crea) [8] , [19] . All five of these markers were elevated in women with recently sustained fracture. However, only two of them, in particular U-DPD/crea but also ULongOC/crea, were also elevated in those women who were least physically active at the time of sampling. The reason for this latter finding is probably due to the limited discriminative power of the activity scores used. Also, there were considerably less women in the low activity grades compared to the intermediate and high grades, and we cannot exclude that the absence of a connection, for also the other resorption markers, between low physical activity and bone resorption is due to insufficient power of the study for this specific question. It is likely that these five markers actually represent different aspects of bone resorption, whether the resorption is directly dependent on the immobilized status or is more of a consequence of the metabolic remodelling events taking place at the specific skeletal fracture location.
There are some specific advantages with the study design used in this paper. All women had the same age, 75, making age corrections unnecessary. In addition all women were of Caucasian ancestry and recruited from the same catchment area, Malmö city, Sweden.
Fracture registration throughout life was made possible by the quite unique situation at the department of radiology, in this city, where all radiographs, referrals and reports have been saved for one hundred years. This situation throughout the 20 th century has resulted in a considerable number of papers on fracture epidemiology [29] . We cannot exclude, however, that some of the women included in this study, and in particular a long time ago, refrained from radiographic examination after fracture trauma. Therefore, we may have missed some fractures from registration and, in particular, fractures sustained when the women were still young. If so, this would, however, have no influence on the conclusions drawn from this study. Furthermore, the lifetime prevalence of fracture did not differ between participating women (n=1024) and the entire cohort of invited women (n=1604) for whom we were able to search the files and/or register fractures by questioning. This leads us also to believe that the sampled women could be judged to represent fairly well the entire population.
There are also some limitations with this study. Since all the women were of the same age, we cannot generalize the results to be valid for both sexes and at all ages. We find no reason to believe, however, that the results should not be commonly valid for elderly women well above menopausal age.
For some of the markers, in particular, S-CTX, there is an influence of non fasting status on the serum concentration [30] . At the time of initiating this study in 1995, knowledge of this was not available. In spite of this, S-CTX did appear to react to fracture in a comparable way with the other resorption markers, in particular, S-TRACP5b, which is known to be considerably less dependent of fasting status [31] . In general there was no difference in fasting status between ever-fractured women, and never-fractured women.
There is evidence that retrospectively sustained fracture is a strong independent predictor of new fractures [32 33] . Also, biochemical markers of bone turnover have been used to predict forthcoming fractures [9] [10] [11] [12] [13] [14] [15] [16] [17] . In particular, high levels of resorption markers, such as S-CTX [12] and S-TRACP5b [19] , have been associated with such fractures. There seems also to be convincing evidence that combining marker levels with bone mineral density measurements would further enhance our possibilities to predict fractures [19] [33] . Ideally, we would learn to use already existing and novel biochemical markers that to some extent can add to, or even replace, today's equipment and personnel required for bone density testing. In order to gain such marker-specific knowledge, we need to characterize all the different factors that may influence one or another marker. In conclusion, the results from assessments of markers of bone turnover should be used, with caution if the patient has sustained a fracture within two years prior to sampling. S-CTX, at age 75, and in relation to age when retrospectively sustained fracture occurred.
Women with two or more fractures are denoted only when last fracture occurred. Line indicates a robust locally-weighted regression (Lowess smoothing). U-DPD/crea and U-LongOC/crea at age 75, in relation to current physical activity (2=low, 8=high, for further information see text)(Mean + 0.95 Conf. Interval). 
